ACROPASS TROUBLE CURE (RAPHAS CO.,LTD)
Welcome to the PulseAid listing for the ACROPASS TROUBLE CURE drug offered from RAPHAS CO.,LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | RAPHAS CO.,LTD |
NON-PROPRIETARY NAME: | HYALURONIC ACID, NIACINAMIDE |
SUBSTANCE NAME: | HYALURONIC ACID; NIACINAMIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | PATCH |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2016-11-01 |
END MARKETING DATE: | 0000-00-00 |
ACROPASS TROUBLE CURE HUMAN OTC DRUG Details:
Item Description | ACROPASS TROUBLE CURE from RAPHAS CO.,LTD |
LABELER NAME: | RAPHAS CO.,LTD |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .53; .03(mg/.58mg; mg/.58mg) |
START MARKETING DATE: | 2016-11-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 71134-010_855d195c-9ed6-4c07-a003-75edb6bcf622 |
PRODUCT NDC: | 71134-010 |
APPLICATION NUMBER: | |
Other HYALURONIC ACID; NIACINAMIDE Pharmaceutical Manufacturers / Labelers: